Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market
Holding ATTBF?
Track your performance easily

Abattis Bioceuticals (ATTBF) Income Statement

173 Followers

Abattis Bioceuticals Income Statement

Last quarter (Q ), Abattis Bioceuticals's total revenue was C$723.18K, a decrease of -85.92% from the same quarter last year. In Q, Abattis Bioceuticals's net income was C$-907.06K. See Abattis Bioceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 19Sep 18Sep 17Sep 16Sep 15
Total Revenue
C$ 356.88KC$ 356.88KC$ 8.37K--C$ 91.94K
Cost of Revenue
C$ 115.54KC$ 115.54KC$ 1.89K--C$ 29.32K
Gross Profit
C$ 241.34KC$ 241.34KC$ 6.48K--C$ 62.62K
Operating Expense
C$ 4.26MC$ 4.26MC$ 15.84MC$ 7.10MC$ 2.31MC$ 3.14M
Operating Income
C$ 253.02KC$ 253.02KC$ 15.24KC$ -1.38KC$ -16.96KC$ -2.60M
Net Non Operating Interest Income Expense
C$ 15.90KC$ 15.90KC$ -5.19MC$ 2.90KC$ -29.85KC$ -17.02K
Other Income Expense
C$ -6.02KC$ -6.02KC$ 56.50MC$ 828.31KC$ 60.32KC$ 295.08K
Pretax Income
C$ -3.74MC$ -3.74MC$ -77.50MC$ -7.93MC$ -2.41MC$ -5.99M
Tax Provision
-----C$ -419.29K
Earnings From Equity Interest Net Of Tax
--C$ -870.32K--C$ -271.18K
Net Income Common Stockholders
C$ -3.04MC$ -3.04MC$ -78.01MC$ -7.63MC$ -2.34MC$ -4.47M
Basic EPS
C$ -0.01C$ -0.01C$ -0.24C$ -0.06C$ -0.03C$ -0.06
Diluted EPS
C$ -0.01C$ -0.01C$ -0.24C$ -0.05C$ -0.03C$ -0.06
Basic Average Shares
C$ 1.88BC$ 470.49MC$ 322.64MC$ 148.67MC$ 95.00MC$ 68.82M
Diluted Average Shares
C$ 1.88BC$ 470.49MC$ 322.64MC$ 148.67MC$ 95.00MC$ 68.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ -4.37MC$ -4.37MC$ -15.84MC$ -6.36MC$ -2.31MC$ -3.17M
Net Income From Continuing And Discontinued Operation
C$ -3.74MC$ -3.74MC$ -77.50MC$ -7.93MC$ -2.41MC$ -5.57M
Normalized Income
C$ -2.84MC$ -2.41MC$ -14.10MC$ -4.87MC$ -1.72MC$ -3.80M
Interest Expense
------
EBIT
C$ -3.70MC$ -3.70MC$ -73.17MC$ -7.93MC$ -2.38MC$ -5.96M
EBITDA
C$ -3.59MC$ -3.59MC$ -73.14MC$ -7.84MC$ -2.25MC$ -5.77M
Currency in CAD

Abattis Bioceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis